UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

Annals of oncology, 2009-03, Vol.20 (3), p.403-412

2009

Volltextzugriff (PDF)

Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?

European journal of medical research, 2001-08, Vol.6 (8), p.323-332

2001

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1998-07, Vol.12 (7), p.1009-1012

1998

Volltextzugriff (PDF)

Drug-induced apoptosis in chronic lymphocytic leukemia

Leukemia, 1999-11, Vol.13 (11), p.1873-1880

1999

Volltextzugriff (PDF)

4-1BB ligand – just another costimulating molecule?

International journal of clinical pharmacology and therapeutics, 2002-08, Vol.40 (8), p.348-353

2002

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1997-12, Vol.11 Suppl 5, p.S1

1997

Volltextzugriff (PDF)

Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects

European journal of medical research, 2003-10, Vol.8 (10), p.438

2003

Volltextzugriff (PDF)

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Leukemia, 1996-07, Vol.10, p.S23-S31

1996

Volltextzugriff (PDF)

Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents

European journal of medical research, 2006-08, Vol.11 (8), p.313

2006

Volltextzugriff (PDF)

Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma

Anticancer research, 1997-07, Vol.17 (4B), p.3025

1997

Volltextzugriff (PDF)

Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death

International journal of clinical pharmacology and therapeutics, 1998-01, Vol.36 (1), p.25

1998

Volltextzugriff (PDF)

Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma

Anticancer research, 1997-07, Vol.17 (4B), p.3021

1997

Volltextzugriff (PDF)

Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding

Annals of hematology, 1994-07, Vol.69 Suppl 1 (1), p.S13-S17

1994

Volltextzugriff (PDF)

In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels

Clinical cancer research, 1996-06, Vol.2 (6), p.1031-1038

1996

Volltextzugriff (PDF)

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal

Annals of hematology, 1994-07, Vol.69 Suppl 1 (1), p.S25-S29

1994

Volltextzugriff (PDF)

Idarubicin monotherapy in multiply pretreated leukemia patients : response in relation to P-glycoprotein expression

Annals of hematology, 1997-02, Vol.74 (2), p.57-64

1997

Volltextzugriff (PDF)

Cellular resistance as a function within the kinetic network of survival and apoptosis factors

International journal of clinical pharmacology and therapeutics, 2002-08, Vol.40 (8), p.327

2002

Volltextzugriff (PDF)

GM-CSF state of the art and future perspectives

European journal of cancer supplements, 1999, Vol.35 (3)

1999

Volltextzugriff (PDF)

Dentritic cells in AML and MDS-comparison of different FCS-free culture conditions

European journal of cancer (1990), 2001-09, Vol.37, p.S36-S36

2001

Volltextzugriff (PDF)

Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia

European journal of haematology, 1990-07, Vol.45 (1), p.19-25

1990

Volltextzugriff (PDF)

4-1 BB ligand--just another costimulating molecule?

International journal of clinical pharmacology and therapeutics, 2002-08, Vol.40 (8), p.348

2002

Volltextzugriff (PDF)

Colonic mucosal proliferation is related to serum deoxycholic acid levels

Cancer, 1999-04, Vol.85 (8), p.1664-1669

1999

Volltextzugriff (PDF)

Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood

Cancer letters, 1993-04, Vol.69 (2), p.139-148

1993

Volltextzugriff (PDF)

Further characterisation of two different resistant human leukemia cell lines with respect to apoptosis induction

European journal of cancer (1990), 1995-10, Vol.31, p.S34-S34

1995

Volltextzugriff (PDF)

Association of bcl-2, bax, bcl-xl and interleukin-1 β-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia

Leukemia, 1996-07, Vol.10, p.S18-S22

1996

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(49)
Tagungsberichte
(9)

Sprache

Englisch
(50)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Drug-induced apoptosis in chronic lymphocytic leukemia

4-1BB ligand – just another costimulating molecule?

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents

Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma

Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death

Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma

Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding

In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal

Idarubicin monotherapy in multiply pretreated leukemia patients : response in relation to P-glycoprotein expression

Cellular resistance as a function within the kinetic network of survival and apoptosis factors

GM-CSF state of the art and future perspectives

Dentritic cells in AML and MDS-comparison of different FCS-free culture conditions

Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia

4-1 BB ligand--just another costimulating molecule?

Colonic mucosal proliferation is related to serum deoxycholic acid levels

Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood

Further characterisation of two different resistant human leukemia cell lines with respect to apoptosis induction

Association of bcl-2, bax, bcl-xl and interleukin-1 β-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia

Suchergebnisse filtern